Kyriazanos ID, Sfiniadakis I, Gizaris V, Hountis P, Hatziveis K, Dafnopoulou A, et al. The Incidence of Helicobacter pylori Infection Is Not Increased Among Obese Young Individuals in Greece. Journal of Clinical Gastroenterology. 2002;34(5):541–6.
2.
Azuma T. Gastric leptin and Helicobacter pylori infection. Gut. 2001;49(3):324–9.
3.
Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels - A systematic review. BMC Gastroenterology. 2011;11(1).
4.
Carabotti M. Helicobacter pyloriinfection in obesity and its clinical outcome after bariatric surgery. World Journal of Gastroenterology. 2014;20(3):647.
5.
Cho I, Blaser MJ, François F, Mathew JP, Ye XY, Goldberg JD, et al. Helicobacter pylori and Overweight Status in the United States: Data from the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology. 2005;162(6):579–84.
6.
Hussein NR, Robinson K, Atherton JC. A study of Age‐Specific Helicobacter pylori Seropositivity Rates in Iraq. Helicobacter. 2008;13(4):306–7.
7.
Bardhan PK. Epidemiological Features ofHelicobacter pyloriInfection in Developing Countries. Clinical Infectious Diseases. 1997;25(5):973–8.
8.
Isomoto H, Nakazato M, Ueno H, Date Y, Nishi Y, Mukae H, et al. Low plasma ghrelin levels in patients with Helicobacter pylori–associated gastritis. The American Journal of Medicine. 2004;117(6):429–32.
9.
Konturek PC, Czesnikiewicz-Guzik M, W B. Involvement of Helicobacter pylori infection in neuro-hormonal control of food intake. J Physiol Pharmacol. 2006;
10.
van de Wouw BA, de Boer WA, Jansz AR, Roymans RT, Staals AP. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. Journal of Clinical Microbiology. 1996;34(1):94–7.
11.
Talley NJ, Newell DG, Ormand JE, Carpenter HA, Wilson WR, Zinsmeister AR, et al. Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. Journal of Clinical Microbiology. 1991;29(8):1635–9.
12.
Nwokolo CU. Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003;52(5):637–40.
13.
Koike T, Ohara S, Sekine H, Iijima K, Kato K, Toyota T, et al. Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Alimentary Pharmacology & Therapeutics. 2001;15(6):813–20.
14.
Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Risk factors associated with symptoms of gastroesophageal reflux. The American Journal of Medicine. 1999;106(6):642–9.
15.
Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1960-1962 through 2009-2010. 2012.
16.
Labenz J, Blum A, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 1997;112(5):1442–7.
17.
Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Digestive and Liver Disease. 2005;37(1):39–43.
18.
Fujiwara Y, Higuchi K, UA A. Longterm effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepato-Gastroenterology. 2002;49:1298–302.
19.
Rogha M, Dadkhah D, Z P. Association of helicobacter pylori infection with severity of coronary heart disease. ARYA Atherosclerosis. 2012;7(138).
20.
SAIJO Y, UTSUGI M, YOSHIOKA E, HORIKAWA N, SATO T, GONG Y, et al. Relationship of Helicobacter pylori Infection to Arterial Stiffness in Japanese Subjects. Hypertension Research. 2005;28(4):283–92.
21.
Parsonnet J. HELICOBACTER PYLORI AND GASTRIC CANCER. Gastroenterology Clinics of North America. 1993;22(1):89–104.
22.
Cover TL, Blaser MJ. Helicobacter pylori in Health and Disease. Gastroenterology. 2009;136(6):1863–73.
23.
ROBINWARREN J. UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS. The Lancet. 1983;321(8336):1273–5.
24.
Hammond R, Levine. The economic impact of obesity in the United States. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. Volume 3:285–95.
25.
Prentice A, Jebb S. Energy Intake/Physical Activity Interactions in the Homeostasis of Body Weight Regulation. Nutrition Reviews. 2004;62(7):98–104.
26.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA. 2006;295(13):1549.
27.
Flegal KM. Prevalence and Trends in Obesity Among US Adults, 1999-2008. JAMA. 2010;303(3):235.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
